title: Intravenous administration of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts.
authors.affiliation: Department of Surgery, Nihon University, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, Japan 173-8610.
authors.forename: O
authors.initials: O
authors.lastname: Aramaki
authors.forename: T
authors.initials: T
authors.lastname: Takayama
authors.forename: T
authors.initials: T
authors.lastname: Yokoyama
authors.forename: S
authors.initials: S
authors.lastname: Takano
authors.forename: Y
authors.initials: Y
authors.lastname: Akiyama
authors.forename: S
authors.initials: S
authors.lastname: Shibutani
authors.forename: N
authors.initials: N
authors.lastname: Shirasugi
authors.forename: S
authors.initials: S
authors.lastname: Kan
authors.forename: Y
authors.initials: Y
authors.lastname: Ikeda
authors.forename: M
authors.initials: M
authors.lastname: Niimi
mesh_terms: D000818:Animals; D000990:Antithrombin III / Q000008:administration & dosage / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000096:biosynthesis; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007275:Injections, Intravenous; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D016207:Cytokines; D000990:Antithrombin III